169 related articles for article (PubMed ID: 23490550)
21. Functional neuroanatomy of the endocannabinoid system.
Pazos MR; Núñez E; Benito C; Tolón RM; Romero J
Pharmacol Biochem Behav; 2005 Jun; 81(2):239-47. PubMed ID: 15936805
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoids and the skeleton: from marijuana to reversal of bone loss.
Bab I; Zimmer A; Melamed E
Ann Med; 2009; 41(8):560-7. PubMed ID: 19634029
[TBL] [Abstract][Full Text] [Related]
23. Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategies.
Janero DR; Vadivel SK; Makriyannis A
Int Rev Psychiatry; 2009 Apr; 21(2):122-33. PubMed ID: 19367506
[TBL] [Abstract][Full Text] [Related]
24. Gut feelings about the endocannabinoid system.
Di Marzo V; Piscitelli F
Neurogastroenterol Motil; 2011 May; 23(5):391-8. PubMed ID: 21481098
[TBL] [Abstract][Full Text] [Related]
25. Involvement of the opioid and cannabinoid systems in pain control: new insights from knockout studies.
Nadal X; La Porta C; Andreea Bura S; Maldonado R
Eur J Pharmacol; 2013 Sep; 716(1-3):142-57. PubMed ID: 23523475
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.
Svízenská I; Dubový P; Sulcová A
Pharmacol Biochem Behav; 2008 Oct; 90(4):501-11. PubMed ID: 18584858
[TBL] [Abstract][Full Text] [Related]
27. Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon-β: a longitudinal study in multiple sclerosis patients.
Sánchez López AJ; Román-Vega L; Ramil Tojeiro E; Giuffrida A; García-Merino A
Clin Exp Immunol; 2015 Jan; 179(1):119-27. PubMed ID: 25169051
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors.
Saario SM; Laitinen JT
Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):287-93. PubMed ID: 17910610
[TBL] [Abstract][Full Text] [Related]
29. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.
Onaivi ES; Ishiguro H; Gong JP; Patel S; Perchuk A; Meozzi PA; Myers L; Mora Z; Tagliaferro P; Gardner E; Brusco A; Akinshola BE; Liu QR; Hope B; Iwasaki S; Arinami T; Teasenfitz L; Uhl GR
Ann N Y Acad Sci; 2006 Aug; 1074():514-36. PubMed ID: 17105950
[TBL] [Abstract][Full Text] [Related]
30. [Endocannabinoid system and CNR1 gene polymorphisms in schizophrenia and addictive disorders].
Martínez-Gras I; Hoecnika J; Pérez-Hernández E; Rodríguez-Jiménez R; Ponce G; Jiménez-Arriero M; Ramos-Atance J; Palomo T; Rubio G
Actas Esp Psiquiatr; 2007; 35(2):122-9. PubMed ID: 17401783
[TBL] [Abstract][Full Text] [Related]
31. Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis.
Carey CE; Agrawal A; Zhang B; Conley ED; Degenhardt L; Heath AC; Li D; Lynskey MT; Martin NG; Montgomery GW; Wang T; Bierut LJ; Hariri AR; Nelson EC; Bogdan R
J Abnorm Psychol; 2015 Nov; 124(4):860-77. PubMed ID: 26595473
[TBL] [Abstract][Full Text] [Related]
32. Update on the endocannabinoid system as an anticancer target.
Malfitano AM; Ciaglia E; Gangemi G; Gazzerro P; Laezza C; Bifulco M
Expert Opin Ther Targets; 2011 Mar; 15(3):297-308. PubMed ID: 21244344
[TBL] [Abstract][Full Text] [Related]
33. A collaboration investigating endocannabinoid signalling in brain and bone.
Zimmer A
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):229-35. PubMed ID: 26887036
[TBL] [Abstract][Full Text] [Related]
34. Novel CB1-ligands maintain homeostasis of the endocannabinoid system in ω3- and ω6-long-chain-PUFA deficiency.
Hammels I; Binczek E; Schmidt-Soltau I; Jenke B; Thomas A; Vogel M; Thevis M; Filipova D; Papadopoulos S; Stoffel W
J Lipid Res; 2019 Aug; 60(8):1396-1409. PubMed ID: 31167809
[TBL] [Abstract][Full Text] [Related]
35. Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex.
Long LE; Lind J; Webster M; Weickert CS
BMC Neurosci; 2012 Jul; 13():87. PubMed ID: 22827915
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome.
Navarro-Romero A; Galera-López L; Ortiz-Romero P; Llorente-Ovejero A; de Los Reyes-Ramírez L; Bengoetxea de Tena I; Garcia-Elias A; Mas-Stachurska A; Reixachs-Solé M; Pastor A; de la Torre R; Maldonado R; Benito B; Eyras E; Rodríguez-Puertas R; Campuzano V; Ozaita A
Elife; 2022 Oct; 11():. PubMed ID: 36217821
[TBL] [Abstract][Full Text] [Related]
37. Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3.
Rodríguez-Cueto C; Hernández-Gálvez M; Hillard CJ; Maciel P; García-García L; Valdeolivas S; Pozo MA; Ramos JA; Gómez-Ruiz M; Fernández-Ruiz J
Neuroscience; 2016 Dec; 339():191-209. PubMed ID: 27717809
[TBL] [Abstract][Full Text] [Related]
38. Genetic polymorphisms of the endocannabinoid system in obesity and diabetes.
Doris JM; Millar SA; Idris I; O'Sullivan SE
Diabetes Obes Metab; 2019 Feb; 21(2):382-387. PubMed ID: 30129173
[TBL] [Abstract][Full Text] [Related]
39. Role of CB2 cannabinoid receptor in the development of food addiction in male mice.
García-Blanco A; Ramírez-López Á; Navarrete F; García-Gutiérrez MS; Manzanares J; Martín-García E; Maldonado R
Neurobiol Dis; 2023 Apr; 179():106034. PubMed ID: 36775043
[TBL] [Abstract][Full Text] [Related]
40. Genetic variation in the endocannabinoid system and response to Cognitive Behavior Therapy for child anxiety disorders.
Lester KJ; Coleman JR; Roberts S; Keers R; Breen G; Bögels S; Creswell C; Hudson JL; McKinnon A; Nauta M; Rapee RM; Schneider S; Silverman WK; Thastum M; Waite P; Wergeland GJ; Eley TC
Am J Med Genet B Neuropsychiatr Genet; 2017 Mar; 174(2):144-155. PubMed ID: 27346075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
